Virginia Retirement Systems’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Buy
+3,700
New +$335K ﹤0.01% 1026
2026
Q1
Sell
-9,200
Closed -$985K 1046
2025
Q4
$985K Buy
9,200
+2,500
+37% +$265K 0.01% 585
2025
Q3
$677K Buy
+6,700
New +$622K ﹤0.01% 693
2023
Q1
Sell
-8,000
Closed -$233K 1207
2022
Q4
$233K Buy
+8,000
New +$206K ﹤0.01% 1026
2022
Q1
$136K Buy
+11,800
New +$104K ﹤0.01% 1078

Other funds holding RYTM

Virginia Retirement Systems's RYTM Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 3,700 shares worth $411K. The stake represents ﹤0.01% of the portfolio and ranks #1026 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in RYTM as recently as Q4 2025.

Virginia Retirement Systems first reported a position in RYTM in Q1 2022 and has held it in 5 quarters since. The position peaked at $985K in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Virginia Retirement Systems held 3,700 shares of Rhythm Pharmaceuticals worth $411K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Virginia Retirement Systems position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1026 holding.
  • Virginia Retirement Systems first reported a position in Rhythm Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • Virginia Retirement Systems's Rhythm Pharmaceuticals position peaked at $985K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.